HOME >> MEDICINE >> NEWS
Treatment for brain tumor does not always follow recommendations

An examination of how the most common type of primary brain tumor is treated found that care does not always follow established practice guidelines, according to a study in the February 2 issue of JAMA.

Malignant gliomas (brain tumors, grade III or IV) are the most common primary brain tumor, and their incidence is increasing over time, according to background information in the article. These tumors are the second-most common cause of cancer-related death in the young-adult age group and are associated with extensive illness. Despite intensive research, the prognosis for patients with malignant glioma remains poor. Typical survival for patients with grade III glioma is 3 to 5 years and is less than 1 year for patients with glioblastoma multiforme (grade IV glioma). Current treatment for patients with malignant glioma includes maximum safe resection (surgical removal), radiation therapy, and chemotherapy.

Susan M. Chang, M.D., of the University of California, San Francisco, and colleagues conducted a study to provide data to enable comparison of individual practice patterns and outcomes for adults with malignant glioma. The Glioma Outcomes (GO) Project enrolled 788 patients at 52 clinical sites, both academic and community practices, between December 1997 and July 2000. The enrollment criteria included adult patients with primary grade III or IV glioma undergoing a first or second operation for diagnosis or treatment. The data collection instruments included questionnaire forms given at enrollment, during the perioperative period, and at follow-up intervals of 3 months until death or a maximum of 24 months. Of the patients recorded in the GO database, 565 patients with newly diagnosed tumors were used for this analysis.

The researchers found that most patients underwent magnetic resonance imaging (n = 518; 92 percent) and an attempt at tumor resection (n = 425; 75 percent). Most received perioperative corticosteroids (n = 535; 99 perce
'"/>

Contact: Carol Hyman
415-476-2557
JAMA and Archives Journals
1-Feb-2005


Page: 1 2 3

Related medicine news :

1. Treatment of cardiac lesions without anaesthesic
2. Treatment guidelines for kids with bipolar disorder published
3. University of Washington joins new Autism Treatment Network to provide better medical services
4. Advances in Skeletal Anabolic Agents for the Treatment of Osteoporosis: A scientific meeting
5. Treatment of ductal carcinoma in situ varies widely in United States
6. Treatment options expand for patients with neuropathic pain
7. Treatment interruption shows no benefit in drug-resistant HIV infection
8. Peanut Allergy: Major Advances in Treatment and Education
9. Release of results of Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
10. Treatment helped reduce dose of inhaled corticosteroids while maintaining asthma control
11. Treatment for behavioral disorders in children with autism

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/15/2018)... ... November 15, 2018 , ... Associated Urologists ... UroLift® Center of Excellence. The designation recognizes that Dr. Dehner has achieved a ... commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic ...
(Date:11/14/2018)... (PRWEB) , ... November 14, 2018 , ... Acti-Kare ... Searcy, Cabot, Jacksonville, Austin, Ward and Romance, is celebrating its official grand opening with ... Local families are encouraged to like and follow the Acti-Kare Facebook page ...
(Date:11/14/2018)... ... November 14, 2018 , ... Contrary to ... recycled consumer product. Lead batteries hold the honor at a whopping 99.3 percent, ... Day 2018 on November 15, the lead battery industry is proudly sharing the ...
(Date:11/14/2018)... ... November 14, 2018 , ... Nanovis , a leader ... FortiCore® rotatable Posterior Lumbar Interbody Fusion (PLIF) devices. , With over 5,000 FortiCore ... expansion of their FortiCore PLIF product line with the addition of 22 mm and ...
(Date:11/13/2018)... RESEARCH TRIANGLE PARK, N.C. (PRWEB) , ... November ... ... the biopharmaceutical, pharmaceutical, and medical device industries, announced today the opening of its ... Park, Azzur Labs’ state-of-the-art facility aims to provide comprehensive services to top U.S. ...
Breaking Medicine News(10 mins):
(Date:11/15/2018)... ... November 15, 2018 , ... ... announced today that it is now offering its flagship phishing simulation platform to ... of damaging Security Breaches. The Symbol Platform is designed to seamlessly allow ...
(Date:11/14/2018)... (PRWEB) , ... November 14, ... ... audit, Aspirus Medevac is being awarded accreditation for their ground ... of Medical Transport Applications (NAAMTA). , NAAMTA Accreditation is founded ...
(Date:11/13/2018)... (PRWEB) , ... November 13, 2018 , ... ... the CCW100 pool sanitation system. The pool plumbing Manifold enables homeowners and pool ... are now available to order. , Clear Comfort pool systems can now use ...
Breaking Medicine Technology:
Cached News: